ABIONYX Pharma SA (EPA:ABNX)
France · Delayed Price · Currency is EUR 3.695
+0.015 (0.41%)
Apr 2, 2026, 5:35 PM CET
ABIONYX Pharma Market Cap
ABIONYX Pharma has a market cap or net worth of €130.35 million as of April 2, 2026. Its market cap has increased by 194.60% in one year.
Market Cap
130.35M
Enterprise Value
131.10M
Revenue
4.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.70
Market Cap Chart
Since March 30, 2015, ABIONYX Pharma's market cap has decreased from 214.16M to 130.35M, a decrease of -39.13%. That is a compound annual growth rate of -4.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 130.35M | -2.38% |
| Dec 31, 2025 | 133.53M | 223.58% |
| Dec 31, 2024 | 41.27M | -0.54% |
| Dec 29, 2023 | 41.49M | -14.37% |
| Dec 30, 2022 | 48.45M | -28.38% |
| Dec 31, 2021 | 67.65M | 178.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genfit | 429.73M |
| Sensorion | 218.76M |
| Cellectis | 218.50M |
| Transgene | 209.75M |
| MaaT Pharma | 108.76M |
| Innate Pharma | 105.35M |
| Adocia | 95.32M |
| OSE Immunotherapeutics | 73.36M |